FDA recall record

Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube recall — FDA D-1497-2022

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Class IIclassification
D-1497-2022official record ID
Sep 7, 2022report date

Recall record at a glance

Official recordD-1497-2022
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmPadagis US LLC
Report dateSep 7, 2022
Recall initiation dateAug 17, 2022
Quantity57,816 tubes
LocationMinneapolis, MN, United States

Official product description

Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed By Perrigo, Allegan, MI 49010, NDC 45802-064-36.

Why the product was recalled

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Distribution information

Nationwide in the USA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugMar 22, 2023

Evamist recall — FDA D-0464-2023

Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.

Class IIIFDA: OngoingPadagis US LLC